Titan Medical Inc.(Us) (TSE:TMD) has released an update.
Titan Medical Inc. is progressing toward finalizing its merger with Conavi Medical Inc., as both companies work to meet the closing conditions stipulated in their March 17, 2024 Amalgamation Agreement. Key steps include preparing for TSX Venture Exchange approval, completing a joint management information circular for shareholder voting, and securing at least US$15 million through Conavi’s financing of subscription receipts. The merger aims to enhance Titan’s position in the robotic assisted surgery market.
For further insights into TSE:TMD stock, check out TipRanks’ Stock Analysis page.
